Laboratorio Reig Jofre, S.A
Budget
€10 — €0
EP Access
0
accredited persons
Staff
4
0.4 FTE
EU Grants
None
Mission & Goals
Reig Jofre is a pharmaceutical company dedicated to the research, development, manufacturing, and commercialization of pharmaceutical products that are essential to human health. Its operations are structured into three main business areas: Pharmaceutical Technologies, Specialty Pharmacare, and Consumer Healthcare. The company operates in four development and production centers in Europe (two in Toledo, one in Barcelona, and one in Malmö) and has subsidiaries in eight countries. Listed under the ticker “RJF,” Reig Jofre is traded on the Spanish continuous stock market. The company’s international expansion strategy has been key to fulfilling its mission of delivering essential solutions to a global audience. Through its presence in diverse markets and strategic partnerships, Reig Jofre has not only broadened its reach but also enhanced its innovative capacity. This has strengthened its industry position and ensured its products and services positively impact communities worldwide.
EU Legislative Interests
Reig Jofre is actively involved with a number of critical European-level policy initiatives and legislative proposals. We work to influence and contribute to EU efforts in strengthening the pharmaceutical sector, improving resilience in medical supply chains, and promoting innovation in advanced therapies. Specifically, our interest representation covers EU policies and projects related to strategic autonomy in health, the pharmaceutical value chain, manufacturing innovation, and public–private health consortia: Reig Jofre actively contributes to several European initiatives aligned with our mission to strengthen the EU’s health resilience, pharmaceutical autonomy, and innovation capacity. These are examples of recent EU initiatives, policies, or files we target: Pharmaceutical Strategy for Europe EU Pharmaceutical Reform: Incentives to steer innovation and achieve public health objectives IPCEI Med4Cure (Important Project of Common European Interest) EU Health Emergency Preparedness and Response Authority (HERA) initiatives Critical Medicines Alliance EU-FAB initiative European Commission Communication on Strengthening the Pharmaceutical Supply Chain Interregional Innovation Investments (I3) Instrument Horizon Europe
Interests Represented
Promotes their own interests or the collective interests of their members
Commissioner Meetings
No recorded meetings with EU commissioners.